COMMUNIQUÉS West-GlobeNewswire

Telix Pharmaceuticals and Osaka University receive Japan Science and Technology Agency Funding for Alpha Nuclide Research
30/05/2018
KYOTO and OSAKA, Japan, May 30, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of diagnostic and [...]
Keryx Pharmaceuticals Announces Upcoming Investor Presentations
30/05/2018
BOSTON, May 29, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today announced two upcoming [...]
Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2018
29/05/2018
Initiated a Phase 1 trial of SRF231, a fully human antibody targeting CD47 Completed upsized initial public offering and concurrent private placement raising a total of $119.5 million in gross proceeds CAMBRIDGE, Mass [...]
Dova Pharmaceuticals to Present at Jefferies 2018 Healthcare Conference
29/05/2018
DURHAM, N.C., May 29, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) today announced that Alex Sapir, President and Chief Executive Officer, will present a company overview at the Jefferies 2018 [...]
Kiniksa Pharmaceuticals, Ltd. Announces Closing of Initial Public Offering
29/05/2018
HAMILTON, Bermuda, May 29, 2018 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA ) (“Kiniksa”) announced today the closing of its initial public offering of 8,477,777 Class A common shares at a public [...]
Endocyte to Present at Jefferies Healthcare Conference
29/05/2018
WEST LAFAYETTE, Ind., May 29, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq: ECYT ), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that the company’s [...]
Voyager Therapeutics Announces Management Change
29/05/2018
CAMBRIDGE, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR ), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases today [...]
Cara Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference
29/05/2018
STAMFORD, Conn., May 29, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA ), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and [...]
Oxford Immunotec to Present at the Jefferies 2018 Healthcare Conference
29/05/2018
OXFORD, United Kingdom and MARLBOROUGH, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD ), a global, high-growth diagnostics company, today announced that Rick Altieri, Chief Financial [...]
T2 Biosystems Announces Proposed Public Offering of Common Stock
29/05/2018
LEXINGTON, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (Nasdaq: TTOO ), an emerging leader in the development and commercialization of innovative diagnostic products for critical unmet needs in [...]
Sol-Gel Technologies Announces Participation in Upcoming Investor Conferences
29/05/2018
NESS ZIONA, Israel, May 29, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ: SLGL ) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing [...]
Melinta Therapeutics Announces Closing of Underwritten Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock
29/05/2018
NEW HAVEN, Conn., May 29, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]
Atara Biotherapeutics to Participate at Two Upcoming Investor Conferences
29/05/2018
SOUTH SAN FRANCISCO, Calif., May 29, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Invuity to Present at William Blair Annual Growth Stock Conference
29/05/2018
SAN FRANCISCO, May 29, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY ), a leading medical technology company focused on minimal access surgery, today announced that company management is scheduled to present at [...]
Mesoblast Financial Results Webcast for Quarter Ended March 31, 2018
29/05/2018
NEW YORK and MELBOURNE, Australia, May 29, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: MESO ) (ASX:MSB) will report financial results for the quarter ended March 31, 2018 in a webcast beginning at 6:30 pm on [...]
Agility Health Announces Delay in Filing Quarterly Financial Results and Management Cease Trade Order Update
29/05/2018
HAMILTON, Ontario, May 29, 2018 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV:AHI) (“ Agility Health ” or “ Corporation ”), a leading provider of orthotics, prosthetics and foot care services in Canada, announces that [...]
CyberFuels Inc. Announces Completion of Test and Initial Order for EcoFlex 96 from Russia
29/05/2018
PALM BEACH GARDENS, Fla., May 29, 2018 (GLOBE NEWSWIRE) -- EncounterCare Solutions Inc. (Pink sheets:ECSL) wholly owned subsidiary CyberFuels, Inc. is pleased to announce that CyberFuels has received its first order for [...]
VitalHub Reaches Profitability in Q1 While Recognizing $2.9 Million in Revenue
29/05/2018
TORONTO, May 29, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV:VHI) announced today it has filed its Consolidated Financial Statements and Management's Discussion and Analysis report for [...]
Indiana Biosciences Research Institute names vice president for advancement
29/05/2018
INDIANAPOLIS, May 29, 2018 (GLOBE NEWSWIRE) -- The Indiana Biosciences Research Institute (IBRI) today announced the appointment of Stephanie Grinage as vice president for Advancement. As IBRI’s top development officer [...]

Pages